Biochemical and pharmacological check-up in emergency orientation;Bilans biochimiques et pharmacologiques d'orientation en urgence

Annales de Biologie Clinique

Volumn 61, Issue 1, 2003, Pages 5-13

  Feugeas, J P ^a   Manchon, M ^b   Augereau, C ^c   Derache, P ^d   Guerber, F ⁱ   Kahn, F ^e   Lefevre G ^f   Magny, E ^g   Merlin, M ^h   Frey, J ⁱ  

^a SAINT LOUIS HOSPITAL   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e BECKMAN COULTER INC   (United States)

^f HÔPITAL TENON   (France)

^g HÔPITAL LARIBOISIÈRE   (France)

^h INSTITUT PAOLI CALMETTES   (France)

ⁱ NONE

Author keywords

Biochemical check up; Emergency; Pharmacological check up

Indexed keywords

BIOLOGICAL MARKER;

BLOOD ANALYSIS; DIAGNOSTIC TEST; EMERGENCY; HUMAN; PREDICTION AND FORECASTING; REVIEW;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; DIAGNOSTIC TESTS, ROUTINE; EMERGENCIES; HUMANS; PREDICTIVE VALUE OF TESTS;

EID: 0037279860     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Steffen MW, Gillen JL, Fuhrman SA. Delivering clinical laboratory services to intensive care units. Clin Chem 1996; 42: 387-91.
2. Arya SC, Varma A. Emergency medicine and bedside tests. J Emerg Med 2001; 20: 86-7.
3. Seguin P, Bleichner P, Grolier J, Guillou M, Malledant Y. Effects of price information on test ordering in an intensive care unit. Intensive Care Med 2002; 28: 332-5.
4. Lewis S, Foreman J. Low-cost diagnostic technologies and clinical outcomes. The impact of inappropriate utilization. Int J Technol Assess Health Care 1997; 13: 501-11.
5. Vassault A, Grafmeyer D, de Graeve J, Cohen R, Beaudonnet A, Bienvenu J. Analyses de biologie médicale: spécifications et normes d'acceptabilité à l'usage de la validation technique. Ann Biol Clin 1999; 57: 685-95.
6. Burtis CA, Ashwood ER. Tietz Texbook of clinical chemistry. Philadelphie: WB Saunders, 1999: 785-8.
7. Fontanarosa PB. An evidence based approach to diagnostic testing in emergency medicine. Emerg Med Clin North Am 1999; 17: 1-8 vii.
8. Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med 2000; 342: 1493-9.
9. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342: 1581-9.
10. Adrogue HJ, Madias NE. Management of life-threating acid-base disorders, part I. N Engl J Med 1998; 338: 26-34.
11. Adrogue HJ, Madias NE. Management of life-threating acid-base disorders, part II. N Engl J Med 1998; 338: 107-11.
12. Halperin ML, Kamel KS. Potassium, Lancet 1998; 352: 135-40.
13. Fournier A, Puy M, de Cagny B. Chlorémie - Chlorurie. In: Kamoun P. Fréjaville JP, eds. Guide des examens de laboratoire. Paris: Médecine-Sciences-Flammarion. 1993: 569-72.
14. Anders HJ, Rihl M, Loch O, Schattenkirchner M. Prediction of creatinine clearance from serum creatinine in patients with rheumatoid arthritis: comparison of six formulae and one nomogram. Clin Rheumatol 2000; 19: 26-9.
15. Daudon M, Raby N, Augereau C, et al. Valeur séméiologique des paramètres biochimiques urinaires. Ann Biol Clin 2001; 59: 13-25.
16. Wallace TM, Meston NM, Gardner SG, Matthews DR. The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice. Diabet Med 2001; 18: 640-5.
17. Mockel M, Gerhardt W, Heller G Jr, et al. Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes. Clin Chim Acta 2001; 303: 167-79.
18. Lefèvre G. Les troponines: aspects biologiques et cliniques. Ann Biol Clin 2000; 58: 39-48.
19. Christenson RH, Duh SH, Sanhai WR, et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001; 47: 464-70.
20. Struthers AD. Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only. Heart 2002; 87: 97-8.
21. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000; 342: 1266-71.
22. Chase CW, Barker DE, Russell WL, Burns RP. Serum amylase and lipase in the evaluation of acute abdominal pain. Am Surg 1996; 62: 1028-33.
23. Keim V, Teich N, Fiedler F, Hartig W, Thiele G, Mossner J. A comparison of lipase and amylase in the diagnosis of acute pancreatitis in patients with abdominal pain. Pancreas 1998; 16: 45-9.
24. Corsetti JP, Cox C, Schulz TJ, Arvan DA. Combined serum amylase and lipase determinations for diagnosis of suspected acute pancreatitis. Clin Chem 1993; 39: 2495-9.
25. Kemppainen EA, Hedstrom JI, Puolakkainen PA, Haapiainen RK, Stenman UH. Advances in the laboratory diagnostics of acute pancreatitis. Ann Med 1998; 30: 169-75.
26. Neoptolemos JP, Kemppainen EA, Mayer JM, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicenter study. Lancet 2000; 355: 1955-60.
27. van Dissel JT. Procalcitonin and other markers of infection. What should be their role in clinical practice? Clin Microbiol Infect 2002; 8: 70-3.
28. Buckley RG, King KJ, Disney JD, Riffenburgh RH, Gorman JD, Klausen JH. Serum progesterone testing to predict ectopic pregnancy in symptomatic first-trimester patients. Ann Emerg Med 2000; 36: 95-100.
29. Phipps MG, Hogan JW, Peipert JF, Lambert-Messerlian GM, Canick JA, Seifer DB. Progesterone. inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies. Obstet Gynecol 2000; 95: 227-31.
30. Vernet M, Corberand J, David V, et al. Algorithmes de prescription recommandés pour le diagnostic d'un déficit et d'une surcharge en fer. Ann Biol Clin 2001; 59: 149-55.
31. Pechard A, Besson AS, Mialon A, Berny C, Manchon M. Analyse critique des différentes méthodes utilisées pour le dépistage toxicologique dans un laboratoire d'urgence. Ann Biol Clin 1999; 57: 525-37.